Manufacturing of high quality cell and gene therapy products
SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.
We attended ISCT 2024
May 29 – April 1, 2024 in Vancouver
We attended German Biotech Days
April 16 - April 17, 2024 in Berlin
We attended EMBT global conference
April 14- April 17, 2024 in Glasgow
We attended to Cell & gene on the Med
April 09 - April 11, 2024 in Roma
SCTbio Brochure
SCTbio Your Reliable Partner for Cell & Gene Therapy GMP Manufacturing
SCTbio Brochure for Analytical Services
Check-out SCTbio full range of analytical capabilities!
We will attend to Advanced Therapies Congress
March 19-20, 2024 in London
We attended BIO-EUROPE FALL
November 6 - November 8, 2023 in Munich Germany
We attended ESGCT 30th ANNUAL CONGRESS
October 24 - October 27, 2023 in Brussels, Belgium
SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation and Logistics Capabilities in Europe
Source: Press Release - Prague, Czech Republic and Vienna, Austria
Orgenesis Announces Collaboration Agreement with SCTbio for the Production of Lentivirus Vectors
Source: Press Release - Germantown, MD and Prague, Czech Republic
We attended ISCT
May 31- June 3, 2023 in Paris, France
We attended The American Society of Gene & Cell Therapy (ASGCT)
May 16-20iest, 2023 in Los Angeles, California, USA
We attended Cell & Gene Meeting on the Med
April 12-14th, 2023 in Barcelona, Spain
We attended 10th Gene Quantification Event
March 20-24th, 2023 in Weihenstephan, Germany
We attended Advanced Therapies Congress
March 14-15th, 2023 in London, UK
We attended the CAR-TCR Europe
February 21-23rd, 2023 in London, UK
We attended the Viral Vector Process Development Summit
January 31- February 2nd, 2023 in Boston, MA, US
We attended the Advanced Therapies Week
January 17-23rd, 2023 in Miami, Florida, US
We attended to Cell & Gene Therapy Manufacturing & Commercialization Europe 2022
December 6-8th, 2022 in Amsterdam, NL
We attended to 3rd CELL & GENE ROUNDTABLE "X-CELLERATOR"
October 20th, 2022 in Berlin, Germany
We attended to Cell & Gene on the Mesa
October 11-13th, 2022 in Carlsbad, CA
We attended to Nordic Life Sciences Days
September 28-29th, 2022 in Malmo, Sweden
We attended to 6th International Symposium on CAR T cells (CAR T Day)
September 7-9th, 2022 in Lille, France
We attended to Advanced Therapies Europe
August 31st - September 1st, 2022 in London, UK
We attended the Advanced Therapies 2022 Congress
May 24-25, 2022 in London, UK
We attended the ASGCT 25th Annual Meeting
May 16-19, 2022 in Washington, D.C.
SCTbio Video
Take a tour of our GMP manufacturing facility in Prague.
Ukázka článku - Media
Praesent nec arcu lorem. Nulla vitae malesuada nisl, nec laoreet enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cambridge
SOTIO, LLC
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA
Prague
SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic
Bejing
SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic
Manufacturing of high quality cell and gene therapy products
SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.
Manufacturing of high quality cell and gene therapy products
SCTbio offers its partners the highest quality services by delivering an engaging, methodical, and cost-effective approach to GMP manufacturing, quality control, process development and logistics services for your cell and gene therapy and viral vector manufacturing needs.
Leading engine
for the field of cell
and gene therapy
SCTbio is a stand-alone contract manufacturing organization offering full GMP services covering production of Advanced Therapy Medicinal Products (ATMPs) including genetically modified and viral vectors. It is a part of PPF Biotech network. The SCTbio mission is to serve as the leading engine for the rapidly advancing field of cell and gene therapy by offering a superior approach to GMP manufacturing for its partners.
Services
SCTbio offers its capacities in the GMP manufacturing facility in Prague. The SCTbio expert team is available to manage technology transfers of products in any stage of preclinical/clinical development and to accommodate it to high cGMP standards.
cGMP Manufacturing
& Quality Control
Analytical
Development
Process
Development
Logistics Services
& Apheresis Collection
Procurement
& Warehouse Management
Quality & Regulatory Support
& Qualified Person Services
Facilities
SCTbio is proud to be a global organization, operating facilities in two continents which include GMP cell therapy manufacturing facilities in Prague, Czech Republic and Beijing, China. SCTbio has also access to a viral vector manufacturing facility operated by its affiliated company based in Cambridge, MA, USA.
Cambridge
SOTIO, LLC
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA
Prague
SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic
Bejing
Manufacturing Facility SCTbio
Beijing Economic-Technological Dev. Area,
99 Kechuang 14, 30-B,
Beijing 100176, China